• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双脱氢皮质抑素A抑制HIV-1反式激活因子介导的神经炎症,并预防Tat转基因小鼠中可卡因奖赏效应的增强。

Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice.

作者信息

Mediouni Sonia, Jablonski Joseph, Paris Jason J, Clementz Mark A, Thenin-Houssier Suzie, McLaughlin Jay P, Valente Susana T

机构信息

Department of Infectious diseases, The Scripps Research Institute, 130 Scripps Way, 3C1, Jupiter, FL 33458, USA.

出版信息

Curr HIV Res. 2015;13(1):64-79. doi: 10.2174/1570162x13666150121111548.

DOI:10.2174/1570162x13666150121111548
PMID:25613133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4416414/
Abstract

HIV-1 Tat protein has been shown to have a crucial role in HIV-1-associated neurocognitive disorders (HAND), which includes a group of syndromes ranging from undetectable neurocognitive impairment to dementia. The abuse of psychostimulants, such as cocaine, by HIV infected individuals, may accelerate and intensify neurological damage. On the other hand, exposure to Tat potentiates cocaine-mediated reward mechanisms, which further promotes HAND. Here, we show that didehydro-Cortistatin A (dCA), an analog of a natural steroidal alkaloid, crosses the blood-brain barrier, cross-neutralizes Tat activity from several HIV-1 clades and decreases Tat uptake by glial cell lines. In addition, dCA potently inhibits Tat mediated dysregulation of IL-1β, TNF-α and MCP-1, key neuroinflammatory signaling proteins. Importantly, using a mouse model where doxycycline induces Tat expression, we demonstrate that dCA reverses the potentiation of cocaine-mediated reward. Our results suggest that adding a Tat inhibitor, such as dCA, to current antiretroviral therapy may reduce HIV-1-related neuropathogenesis.

摘要

HIV-1反式激活因子蛋白已被证明在与HIV-1相关的神经认知障碍(HAND)中起关键作用,HAND包括从难以检测到的神经认知障碍到痴呆症的一系列综合征。感染HIV的个体滥用精神兴奋剂,如可卡因,可能会加速和加剧神经损伤。另一方面,接触反式激活因子会增强可卡因介导的奖赏机制,这进一步促进了HAND。在此,我们表明,天然甾体生物碱的类似物双脱氢皮质抑素A(dCA)可穿过血脑屏障,交叉中和来自多个HIV-1分支的反式激活因子活性,并减少神经胶质细胞系对反式激活因子的摄取。此外,dCA能有效抑制反式激活因子介导的白细胞介素-1β、肿瘤坏死因子-α和单核细胞趋化蛋白-1(关键的神经炎症信号蛋白)的失调。重要的是,利用强力霉素诱导反式激活因子表达的小鼠模型,我们证明dCA可逆转可卡因介导的奖赏增强作用。我们的结果表明,在当前的抗逆转录病毒疗法中添加一种反式激活因子抑制剂,如dCA,可能会减少与HIV-1相关的神经病理发生。

相似文献

1
Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice.双脱氢皮质抑素A抑制HIV-1反式激活因子介导的神经炎症,并预防Tat转基因小鼠中可卡因奖赏效应的增强。
Curr HIV Res. 2015;13(1):64-79. doi: 10.2174/1570162x13666150121111548.
2
An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription.一种天然甾体生物碱考地斯塔汀 A 的类似物能有效抑制 Tat 依赖的 HIV 转录。
Cell Host Microbe. 2012 Jul 19;12(1):97-108. doi: 10.1016/j.chom.2012.05.016.
3
Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription.对 Tat 抑制剂去氢皮质甾酮 A 的耐药性是由 HIV-1 转录的基础水平升高介导的。
mBio. 2019 Jul 2;10(4):e01750-18. doi: 10.1128/mBio.01750-18.
4
The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.Tat抑制剂双脱氢皮质抑素A可防止HIV-1从潜伏状态重新激活。
mBio. 2015 Jul 7;6(4):e00465. doi: 10.1128/mBio.00465-15.
5
In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment.体内抑制 HIV 反弹的二去氢皮质甾酮 A,一种 HIV-1 治疗的“阻断-锁定”策略。
Cell Rep. 2017 Oct 17;21(3):600-611. doi: 10.1016/j.celrep.2017.09.080.
6
The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro-Cortistatin A.阻断-锁定策略治疗人类免疫缺陷病毒:二去氢皮质甾酮 A 的经验教训。
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):46-53. doi: 10.1093/infdis/jiaa681.
7
Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat.去氢皮质甾酮 A 通过特异性结合 Tat 的无规则碱性区抑制 HIV-1。
mBio. 2019 Feb 5;10(1):e02662-18. doi: 10.1128/mBio.02662-18.
8
SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice.SRI-32743,一种新型的变构调节剂,可减弱 HIV-1 Tat 蛋白诱导的多巴胺转运体抑制,并减轻 HIV-1 Tat 转基因小鼠中海洛因奖赏的增强作用。
Neuropharmacology. 2022 Dec 1;220:109239. doi: 10.1016/j.neuropharm.2022.109239. Epub 2022 Sep 17.
9
Effects of conditional central expression of HIV-1 tat protein to potentiate cocaine-mediated psychostimulation and reward among male mice.条件性中枢表达 HIV-1tat 蛋白增强雄性小鼠可卡因介导的精神刺激和奖赏效应。
Neuropsychopharmacology. 2014 Jan;39(2):380-8. doi: 10.1038/npp.2013.201. Epub 2013 Aug 15.
10
Didehydro-Cortistatin A: a new player in HIV-therapy?双脱氢皮质抑素A:HIV治疗的新角色?
Expert Rev Anti Infect Ther. 2016;14(2):145-8. doi: 10.1586/14787210.2016.1122525. Epub 2015 Dec 11.

引用本文的文献

1
HIV Tat as a latency reversing agent: turning the tables on viral persistence.作为潜伏逆转剂的HIV反式激活转录蛋白:扭转病毒持续存在的局面。
Front Immunol. 2025 Apr 11;16:1571151. doi: 10.3389/fimmu.2025.1571151. eCollection 2025.
2
Human chromatin remodelers regulating HIV-1 transcription: a target for small molecule inhibitors.调控HIV-1转录的人类染色质重塑因子:小分子抑制剂的作用靶点
Epigenetics Chromatin. 2025 Apr 16;18(1):21. doi: 10.1186/s13072-025-00582-w.
3
Xenon gas as a potential treatment for opioid use disorder, alcohol use disorder, and related disorders.氙气作为阿片类物质使用障碍、酒精使用障碍及相关障碍的一种潜在治疗方法。
Med Gas Res. 2025 Jun 1;15(2):234-253. doi: 10.4103/mgr.MEDGASRES-D-24-00063. Epub 2025 Jan 13.
4
Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder.左乙拉西坦预防人免疫缺陷病毒(HIV)-1 转录激活物转基因小鼠模型中 HIV 相关神经认知障碍的神经生理变化并保护认知功能。
J Pharmacol Exp Ther. 2024 Sep 18;391(1):104-118. doi: 10.1124/jpet.124.002272.
5
SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in mice.SRI-30827,一种新型多巴胺转运体变构调节剂,可减轻HIV-1反式激活因子诱导的小鼠可卡因条件性位置偏爱增强效应。
NeuroImmune Pharm Ther. 2024 Mar 25;3(1):1-6. doi: 10.1515/nipt-2023-0022. Epub 2023 Dec 1.
6
Ripretinib inhibits HIV-1 transcription through modulation of PI3K-AKT-mTOR.里普替尼通过调节 PI3K-AKT-mTOR 抑制 HIV-1 转录。
Acta Pharmacol Sin. 2024 Aug;45(8):1632-1643. doi: 10.1038/s41401-024-01282-z. Epub 2024 Apr 16.
7
Impaired extinction of cocaine seeking in HIV-infected mice is accompanied by peripheral and central immune dysregulation.HIV 感染小鼠可卡因觅药行为的消退受损,伴随外周和中枢免疫失调。
Commun Biol. 2024 Mar 30;7(1):387. doi: 10.1038/s42003-024-06079-8.
8
HIV Reservoirs and Treatment Strategies toward Curing HIV Infection.HIV储存库及治愈HIV感染的治疗策略
Int J Mol Sci. 2024 Feb 23;25(5):2621. doi: 10.3390/ijms25052621.
9
Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis.HIV-1 Tat 蛋白与宿主受体相互作用在 HIV 感染和发病机制中的作用。
Int J Mol Sci. 2024 Jan 30;25(3):1704. doi: 10.3390/ijms25031704.
10
Transcriptional regulation of the HIV-1 inhibitory factor human mannose receptor 1 by the myeloid-specific transcription factor PU.1.HIV-1 抑制因子人甘露糖受体 1 的转录调控由髓系特异性转录因子 PU.1 完成。
J Virol. 2024 Jan 23;98(1):e0170223. doi: 10.1128/jvi.01702-23. Epub 2023 Dec 11.

本文引用的文献

1
Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravir.体外感染人类免疫缺陷病毒并用raltegravir治疗的脑巨噬细胞的细胞因子分泌
BMC Infect Dis. 2014 Jul 11;14:386. doi: 10.1186/1471-2334-14-386.
2
HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.现代抗病毒治疗时代的人类免疫缺陷病毒相关神经认知障碍:患病率、特征、生物标志物及治疗效果
Curr HIV/AIDS Rep. 2014 Sep;11(3):317-24. doi: 10.1007/s11904-014-0221-0.
3
Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.阻断 HIV 转录的策略:聚焦小分子 Tat 抑制剂。
Biology (Basel). 2012 Nov 19;1(3):668-97. doi: 10.3390/biology1030668.
4
Human astrocytes: secretome profiles of cytokines and chemokines.人类星形胶质细胞:细胞因子和趋化因子的分泌组图谱
PLoS One. 2014 Apr 1;9(4):e92325. doi: 10.1371/journal.pone.0092325. eCollection 2014.
5
Reduction of the HIV protease inhibitor-induced ER stress and inflammatory response by raltegravir in macrophages.拉替拉韦减轻巨噬细胞中HIV蛋白酶抑制剂诱导的内质网应激和炎症反应。
PLoS One. 2014 Mar 13;9(3):e90856. doi: 10.1371/journal.pone.0090856. eCollection 2014.
6
Effects of HIV-1 tat on secretion of TNF-α and IL-1β by U87 cells in AIDS patients with or without AIDS dementia complex.HIV-1反式激活因子对伴有或不伴有艾滋病痴呆综合征的艾滋病患者U87细胞分泌肿瘤坏死因子-α和白细胞介素-1β的影响。
Biomed Environ Sci. 2014 Feb;27(2):111-7. doi: 10.3967/bes2014.024.
7
SAMHD1 restricts HIV-1 replication and regulates interferon production in mouse myeloid cells.SAMHD1限制HIV-1在小鼠骨髓细胞中的复制并调节干扰素的产生。
PLoS One. 2014 Feb 19;9(2):e89558. doi: 10.1371/journal.pone.0089558. eCollection 2014.
8
Roles and functions of HIV-1 Tat protein in the CNS: an overview.HIV-1 Tat 蛋白在中枢神经系统中的作用和功能:概述。
Virol J. 2013 Dec 21;10:358. doi: 10.1186/1743-422X-10-358.
9
Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat.由HIV-1调节蛋白Tat的条件性中枢表达所产生的小鼠焦虑样行为。
Psychopharmacology (Berl). 2014 Jun;231(11):2349-60. doi: 10.1007/s00213-013-3385-1. Epub 2013 Dec 19.
10
Effects of conditional central expression of HIV-1 tat protein to potentiate cocaine-mediated psychostimulation and reward among male mice.条件性中枢表达 HIV-1tat 蛋白增强雄性小鼠可卡因介导的精神刺激和奖赏效应。
Neuropsychopharmacology. 2014 Jan;39(2):380-8. doi: 10.1038/npp.2013.201. Epub 2013 Aug 15.